Your browser doesn't support javascript.
loading
Oral anticoagulation cost in primary antiphospholipid syndrome: comparison between warfarin and hypothetical rivaroxaban.
Ciampa, Antonio; Salapete, Chiara; Vivolo, Sabrina; Ames, Paul R J.
Affiliation
  • Ciampa A; Haemostasis Unit, San Giuseppe Moscati Hospital, Avellino, Italy.
  • Salapete C; Haemostasis Unit, San Giuseppe Moscati Hospital, Avellino, Italy.
  • Vivolo S; Haemostasis Unit, San Giuseppe Moscati Hospital, Avellino, Italy.
  • Ames PRJ; Immune Response and Vascular Disease Unit, CEDOC, Nova Medical School/Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal.
Blood Coagul Fibrinolysis ; 29(1): 135-138, 2018 Jan.
Article in En | MEDLINE | ID: mdl-29095760
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiphospholipid Syndrome / Factor Xa Inhibitors / Anticoagulants Type of study: Health_economic_evaluation / Observational_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Blood Coagul Fibrinolysis Journal subject: ANGIOLOGIA / HEMATOLOGIA Year: 2018 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiphospholipid Syndrome / Factor Xa Inhibitors / Anticoagulants Type of study: Health_economic_evaluation / Observational_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Blood Coagul Fibrinolysis Journal subject: ANGIOLOGIA / HEMATOLOGIA Year: 2018 Document type: Article Affiliation country: Italy Country of publication: United kingdom